title: Serum cystatin C level in patients with rheumatoid arthritis after single infusion of infliximab.
authors.forename: M
authors.initials: M
authors.lastname: Kopec-Medrek
authors.forename: M
authors.initials: M
authors.lastname: Widuchowska
authors.forename: A
authors.initials: A
authors.lastname: Kotulska
authors.forename: E
authors.initials: E
authors.lastname: Zycinska-Dębska
authors.forename: E J
authors.initials: EJ
authors.lastname: Kucharz
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000097:blood* / Q000188:drug therapy*; D055316:Cystatin C / Q000097:blood*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000069285:Infliximab; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D017698:Postmenopause / Q000187:drug effects; D011241:Prednisone / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D055316:Cystatin C; D000069285:Infliximab; D011241:Prednisone; D008727:Methotrexate